the development of prescribing Mental health problems (e.g. anxiety); guidelines and workforce Sleep disorders; and development measures. Alcohol and other drug use problems (including pharmacotherapy). Explore options to enhance peer review mechanisms, practice enhancement approaches and disciplinary measures for prescribers who consistently and inappropriately prescribe outside the boundaries of the proposed guidelines. Enhance undergraduate, postgraduate and in-service education programs for the medical, health and human services workforces about the quality management of problems such as pain, mental health problems, sleep disorders and alcohol and other drug problems. Identify opportunities to better support prescribers who feel pressured by patients to provide medications inappropriately. Explore opportunities to enhance the contribution that Supporting pharmacists and pharmacists can make to the care plans of patients. other health professionals Review and, necessary, enhance protocols for pharmacists concerning acceptable practice in the This includes actions to enhance the dispensing of these medications. role of pharmacists in medication Investigate options to improve access to management as well as a range of undergraduate and in-service professional practice enhancement measures for development programs for pharmacists to better utilise this group. It also highlights the need their professional abilities to enhance the quality use for other health professionals to be of these medications. more aware of and involved in the Investigate options to establish or enhance peer appropriate treatment options for review mechanisms and practice enhancement conditions such as pain, anxiety and measures for pharmacists who dispense outside of sleep disorders. protocol boundaries. Enhance the current pharmacy staged supply arrangements. Enhance the quality use of medicines in residential aged care facilities. Enhance the awareness of a range of health and welfare professionals regarding effective treatments for: Pain (acute, chronic non-malignant and cancer); Mental health problems (e.g. anxiety); Sleep disorders; and Alcohol and other drug use problems (including pharmacotherapy). 4 Regulation and monitoring Evaluate the extent to different jurisdictional regulatory models impact on the misuse of these This includes a range of drugs and identify standardisation benchmarks for enhancements to, and standardisation good practice. of, the ways medications are Provide this Framework to the delegate of the regulated and monitored and the ways Secretary of the Department of Health for in which data about pharmaceutical
the development of prescribing guidelines and workforce development measures. Mental health problems (e.g. anxiety); Sleep disorders; and Alcohol and other drug use problems (including pharmacotherapy). Explore options to enhance peer review mechanisms, practice enhancement approaches and disciplinary measures for prescribers who consistently and inappropriately prescribe outside the boundaries of the proposed guidelines. Enhance undergraduate, postgraduate and in-service education programs for the medical, health and human services workforces about the quality management of problems such as pain, mental health problems, sleep disorders and alcohol and other drug problems. Identify opportunities to better support prescribers who feel pressured by patients to provide medications inappropriately. Supporting pharmacists and other health professionals This includes actions to enhance the role of pharmacists in medication management as well as a range of practice enhancement measures for this group. It also highlights the need for other health professionals to be more aware of and involved in the appropriate treatment options for conditions such as pain, anxiety and sleep disorders. Explore opportunities to enhance the contribution that pharmacists can make to the care plans of patients. Review and, necessary, enhance protocols for pharmacists concerning acceptable practice in the dispensing of these medications. Investigate options to improve access to undergraduate and in-service professional development programs for pharmacists to better utilise their professional abilities to enhance the quality use of these medications. Investigate options to establish or enhance peer review mechanisms and practice enhancement measures for pharmacists who dispense outside of protocol boundaries. Enhance the current pharmacy staged supply arrangements. Enhance the quality use of medicines in residential aged care facilities. Enhance the awareness of a range of health and welfare professionals regarding effective treatments for: Pain (acute, chronic non-malignant and cancer); Mental health problems (e.g. anxiety); Sleep disorders; and Alcohol and other drug use problems (including pharmacotherapy). 4 Regulation and monitoring This includes a range of enhancements to, and standardisation of, the ways medications are regulated and monitored and the ways in which data about pharmaceutical Evaluate the extent to different jurisdictional regulatory models impact on the misuse of these drugs and identify standardisation benchmarks for good practice. Provide this Framework to the delegate of the Secretary of the Department of Health for
National%20PDM%20Framework.docx